prednisone has been researched along with Coronary Disease in 70 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Current vasculitis was also associated with abnormal scintigraphy." | 1.32 | Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus. ( Barbieri, A; Leite, WA; Oliveira Filho, JA; Sato, EI; Sella, EM, 2003) |
| " Cox multivariate analysis included: donor age, sex, and weight; recipient sex, age, pre-HT diagnosis, hypertension, diabetes and hyperlipidemia post-HT; number of treated rejections and RS; and immunosuppressive dosage at 3, 6, and 12 months." | 1.32 | Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. ( Angelini, A; Caforio, AL; Feltrin, G; Fortina, AB; Gambino, A; Gerosa, G; Iliceto, S; Piaserico, S; Ramondo, A; Thiene, G; Tona, F; Valente, M, 2004) |
| "The role of hyperlipidemia in graft coronary artery disease (GCAD) is controversial although hyper-triglyceridemia is an independent risk factor." | 1.31 | Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients. ( Bernstein, D; Chin, C; Rosenthal, D, 2000) |
| "Coronary heart disease was also more frequent in PTDM (15 vs." | 1.31 | High incidence of post-transplant diabetes mellitus in Kuwait. ( Al-Mousawi, M; Costandi, JN; Gupta, RK; Johny, KV; Muzairai, I; Nampoory, MR; Ninan, VT; Samhan, M, 2002) |
| "Prednisone dosage was lower in diabetics with EOD at 6 months, but did not differ among the three groups at 12 months." | 1.29 | Heart transplantation in patients with diabetic end-organ damage before transplantation. ( Aleksic, I; Blanche, C; Czer, LS; Dalichau, H; Freimark, D; Nessim, S; Nusser, P; Takkenberg, JJ; Trento, A, 1996) |
| "There was no evidence of causes for the anaphylactic reactions over a two and a half year period." | 1.27 | Life-threatening idiopathic anaphylaxis associated with hyperimmunoglobulinemia E. ( Greenberger, PA, 1984) |
| "Two patients had coronary arteritis diagnosed on postmortem examination." | 1.26 | Ischemic heart disease in systemic lupus erythematosus in the young patient: report of six cases. ( Fallon, JT; Gross, S; Homcy, CJ; Liberthson, RR; Miller, LM, 1982) |
| "Our data demonstrate that hyperlipidemia is a frequent finding in pediatric patients treated with MH and RT, and may be associated with premature coronary artery disease." | 1.26 | Hyperlipidemia in pediatric hemodialysis and renal transplant patients. Associated with coronary artery disease. ( Fine, RN; Heuser, ET; Lipsey, A; Malekzadeh, MH; Mickey, MR; Pennisi, AJ, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 44 (62.86) | 18.7374 |
| 1990's | 15 (21.43) | 18.2507 |
| 2000's | 11 (15.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| COLE, DS | 1 |
| YARROW, S | 1 |
| BRONZINI, A | 1 |
| GATTI, A | 1 |
| TAROLO, GL | 1 |
| FEARNLEY, GR | 2 |
| CHAKRABARTI, R | 1 |
| KERZNER, MS | 1 |
| REDMON, W | 1 |
| Sella, EM | 1 |
| Sato, EI | 1 |
| Leite, WA | 1 |
| Oliveira Filho, JA | 1 |
| Barbieri, A | 1 |
| Caforio, AL | 1 |
| Tona, F | 1 |
| Fortina, AB | 1 |
| Angelini, A | 1 |
| Piaserico, S | 1 |
| Gambino, A | 1 |
| Feltrin, G | 1 |
| Ramondo, A | 1 |
| Valente, M | 1 |
| Iliceto, S | 1 |
| Thiene, G | 1 |
| Gerosa, G | 1 |
| El-Sayed, O | 1 |
| Magorien, RD | 1 |
| Orsini, A | 1 |
| Ferketich, AK | 1 |
| Leier, CV | 1 |
| McMahon, CJ | 1 |
| Su, JT | 1 |
| Taylor, MD | 1 |
| Krishnamurthy, R | 1 |
| Muthupillai, R | 1 |
| Kovalchin, JP | 1 |
| Chung, T | 1 |
| Vick, GW | 1 |
| Tubman, VN | 1 |
| Smoot, L | 1 |
| Heeney, MM | 1 |
| Setoyama, T | 1 |
| Furukawa, Y | 1 |
| Abe, M | 1 |
| Nakagawa, Y | 1 |
| Kita, T | 1 |
| Kimura, T | 1 |
| Hosenpud, JD | 1 |
| Montanaro, A | 1 |
| Hart, MV | 1 |
| Haines, JE | 1 |
| Specht, HD | 1 |
| Bennett, RM | 1 |
| Kloster, FE | 1 |
| Manresa, F | 1 |
| Garau, J | 1 |
| Gausí, C | 1 |
| Baĭsogolov, GD | 1 |
| Shishkin, IP | 1 |
| Greenberger, PA | 1 |
| Askari, AD | 1 |
| Homcy, CJ | 1 |
| Liberthson, RR | 1 |
| Fallon, JT | 1 |
| Gross, S | 1 |
| Miller, LM | 1 |
| Petri, M | 4 |
| Lakatta, C | 1 |
| Magder, L | 1 |
| Goldman, D | 1 |
| Addonizio, LJ | 1 |
| Hsu, DT | 1 |
| Douglas, JF | 1 |
| Kichuk, MR | 1 |
| Michler, RE | 1 |
| Quaegebeur, JM | 1 |
| Smith, CR | 1 |
| Rose, EA | 2 |
| Frierson, JH | 1 |
| May, CM | 1 |
| Pham, SM | 1 |
| Kormos, RL | 1 |
| Kawai, A | 1 |
| Murali, S | 2 |
| Hattler, BG | 1 |
| Demetris, AJ | 1 |
| Griffith, BP | 2 |
| Aleksic, I | 1 |
| Czer, LS | 1 |
| Freimark, D | 1 |
| Dalichau, H | 1 |
| Takkenberg, JJ | 1 |
| Blanche, C | 1 |
| Nessim, S | 1 |
| Nusser, P | 1 |
| Trento, A | 2 |
| Frustaci, A | 3 |
| Chimenti, C | 3 |
| Pieroni, M | 2 |
| Gajarski, RJ | 1 |
| Smith, EO | 1 |
| Denfield, SW | 1 |
| Rosenblatt, HM | 1 |
| Kearney, D | 1 |
| Frazier, OH | 1 |
| Radovancevic, B | 1 |
| Price, JK | 1 |
| Kertesz, NJ | 1 |
| Towbin, JA | 1 |
| Peddi, VR | 1 |
| Whiting, J | 1 |
| Weiskittel, PD | 1 |
| Alexander, JW | 1 |
| First, MR | 1 |
| Maseri, A | 2 |
| Barr, ML | 1 |
| Baker, CJ | 1 |
| Schenkel, FA | 1 |
| McLaughlin, SN | 1 |
| Stouch, BC | 1 |
| Starnes, VA | 1 |
| Chin, C | 1 |
| Rosenthal, D | 1 |
| Bernstein, D | 1 |
| Kolpak, S | 1 |
| Mehler, P | 1 |
| Johny, KV | 1 |
| Nampoory, MR | 1 |
| Costandi, JN | 1 |
| Gupta, RK | 1 |
| Ninan, VT | 1 |
| Samhan, M | 1 |
| Muzairai, I | 1 |
| Al-Mousawi, M | 1 |
| Schroeder, JS | 3 |
| Rider, AK | 2 |
| Stinson, EB | 5 |
| Shumway, NE | 2 |
| Pennisi, AJ | 1 |
| Heuser, ET | 1 |
| Mickey, MR | 1 |
| Lipsey, A | 1 |
| Malekzadeh, MH | 1 |
| Fine, RN | 1 |
| Delmonico, FL | 1 |
| Cosimi, AB | 1 |
| Russell, PS | 1 |
| Tzivoni, D | 1 |
| Licht, A | 1 |
| Eliakim, M | 1 |
| Perez-Gutthann, S | 1 |
| Spence, D | 2 |
| Hochberg, MC | 2 |
| Zeymer, U | 1 |
| Hirschmann, WD | 1 |
| Neuhaus, KL | 1 |
| Bone, LR | 1 |
| Barbir, M | 1 |
| Banner, N | 1 |
| Thompson, GR | 1 |
| Khaghani, A | 1 |
| Mitchell, A | 1 |
| Yacoub, M | 1 |
| Olivari, MT | 2 |
| Kubo, SH | 2 |
| Braunlin, EA | 1 |
| Bolman, RM | 1 |
| Ring, WS | 2 |
| Stone, GW | 1 |
| Rutherford, BD | 1 |
| McConahay, DR | 1 |
| Johnson, WL | 1 |
| Giorgi, LV | 1 |
| Ligon, RW | 1 |
| Hartzler, GO | 1 |
| Meier, B | 1 |
| Gao, SZ | 1 |
| Alderman, EL | 1 |
| Hunt, SA | 2 |
| Valantine, HA | 1 |
| Wiederhold, V | 1 |
| Homans, DC | 1 |
| Wilson, RF | 1 |
| Becker, DM | 1 |
| Chamberlain, B | 1 |
| Swank, R | 1 |
| Hegewald, MG | 1 |
| Girardet, R | 1 |
| Baughman, KL | 1 |
| Kwiterovich, PO | 1 |
| Pearson, TA | 1 |
| Ettinger, WH | 1 |
| Renlund, D | 1 |
| Baumgartner, WA | 1 |
| Augustine, S | 1 |
| Borkon, AM | 1 |
| Gardner, TJ | 1 |
| Reitz, BA | 2 |
| Hess, ML | 1 |
| Hastillo, A | 1 |
| Thompson, JA | 1 |
| Sansonetti, DJ | 1 |
| Szentpetery, S | 1 |
| Barnhart, G | 1 |
| Lower, RR | 2 |
| Uretsky, BF | 1 |
| Reddy, PS | 1 |
| Rabin, B | 1 |
| Lee, A | 1 |
| Hardesty, RL | 1 |
| Bahnson, HT | 1 |
| Jordan, ML | 1 |
| Novick, AC | 1 |
| Steinmuller, D | 1 |
| Braun, W | 1 |
| Buszta, C | 1 |
| Mintz, D | 1 |
| Goormastic, M | 1 |
| Streem, S | 1 |
| Modry, DL | 1 |
| Oyer, PE | 1 |
| Jamieson, SW | 1 |
| Baldwin, JC | 1 |
| Dawkins, KD | 1 |
| McGregor, CG | 1 |
| Moran, M | 1 |
| Donaghue, KC | 1 |
| Clarke, P | 1 |
| Hooper, MJ | 1 |
| Krosch, H | 1 |
| Schäbitz, J | 1 |
| Rikirsch, P | 1 |
| Heinecker, R | 1 |
| Gavrilescu, S | 1 |
| Gavrilescu, M | 1 |
| Drăgulescu, I | 1 |
| Graham, AF | 1 |
| Caves, PK | 1 |
| Harrison, DC | 1 |
| Hollander, CF | 1 |
| Leonard, A | 1 |
| Raij, L | 1 |
| Comty, CM | 1 |
| Wathen, R | 1 |
| Rattazzi, T | 1 |
| Shapiro, FL | 1 |
| Lamy, J | 1 |
| Aron, E | 1 |
| Martin, JC | 1 |
| Weill, J | 1 |
| Goldstein, HM | 1 |
| Castellino, RA | 1 |
| Wexler, L | 1 |
| Kuch, J | 1 |
| Chorzelski, T | 1 |
| Chatty, ME | 1 |
| Deodhar, SD | 1 |
| Dubost, C | 1 |
| Cachera, JP | 1 |
| Lindahl, F | 1 |
| Campbell, DG | 1 |
| Reid, TM | 1 |
| Fannin, TF | 1 |
| Specchia, G | 1 |
| Giannattasio, M | 1 |
| Dander, B | 1 |
| Carstens, PH | 1 |
| Jacobsen, K | 1 |
| Grahame, R | 1 |
| Bluestone, R | 1 |
| Holt, PJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00005436] | 0 participants | Observational | 1991-09-30 | Completed | |||
| Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients[NCT04414735] | 30 participants (Anticipated) | Interventional | 2022-08-17 | Recruiting | |||
| The Use of Extracorporeal Photopheresis as Immunomodulatory Therapy of Subclinical Antibody-mediated Rejection After Lung Transplantation: a Prospective RCT[NCT06112951] | 80 participants (Anticipated) | Interventional | 2023-11-01 | Not yet recruiting | |||
| Defining Mechanisms for Cardiac Allograft Dysfunction to Improve Allograft Longevity and Survival in Heart-Transplant Patients[NCT03102125] | Phase 4 | 376 participants (Anticipated) | Interventional | 2019-10-01 | Recruiting | ||
| Stress Cardiac MRI Using Regadenoson for Evaluation of Nonspecific Allograft Dysfunction[NCT02597543] | Phase 4 | 14 participants (Actual) | Interventional | 2015-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Hospitalization for cardiac related causes after enrollment. Time frame after enrollment (date of cardiac MRI) was 10 months (NCT02597543)
Timeframe: 10 months after enrollment (from date of cardiac MRI)
| Intervention | Participants (Count of Participants) |
|---|---|
| Nonspecific Allograft Dysfunction | 0 |
| Normal Graft Function | 0 |
Late gadolinium enhancement demonstrates myocardial scar by cardiac MRI. This is measured the day of the cardiac MRI scan and is a one time measurement. Time frame is measurement of late gadolinium enhancement from date of heart-transplantation. (NCT02597543)
Timeframe: Range of 1 to 12 years after heart transplantation for subjects and an average of 4 years after heart-transplantation.
| Intervention | percentage of myocardium (Mean) |
|---|---|
| Nonspecific Allograft Dysfunction | 5.7 |
| Normal Graft Function | 1.8 |
T1 values are obtained at the time of the cardiac MRI and indicate the amount of myocardial edema. This was a one time measurement. Outcome measure time frame indicates when T1 values of the left ventricle were obtained in relation to heart-transplantation. (NCT02597543)
Timeframe: Range of 1 to 12 years after heart transplantation for subjects and an average of 4 years after heart-transplantation.
| Intervention | Percentage of myocardium (Mean) |
|---|---|
| Nonspecific Allograft Dysfunction | 44.5 |
| Normal Graft Function | 38.1 |
Myocardial ischemia or infarct occurring from time of enrollment (when cardiac MRI performed) over subsequent 10 month period. (NCT02597543)
Timeframe: 10 months after enrollment (when cardiac MRI was performed)
| Intervention | Participants (Count of Participants) |
|---|---|
| Nonspecific Allograft Dysfunction | 0 |
| Normal Graft Function | 0 |
Myocardial perfusion reserve calculates the increase in myocardial perfusion after stress in comparison to rest. Outcome measure time frame specifies when the myocardial perfusion reserve was obtained in relation to date of heart-transplant for each patient. This was a one time measurement made after heart-transplantation. (NCT02597543)
Timeframe: Range of 1 to 12 years after heart transplantation for subjects and an average of 4 years after heart-transplantation.
| Intervention | arbitrary units (Mean) |
|---|---|
| Nonspecific Allograft Dysfunction | 1.52 |
| Normal Graft Function | 1.94 |
Re-transplantation of the heart after enrollment (date of cardiac MRI). Measured 10 months after enrollment. (NCT02597543)
Timeframe: 10 months after enrollment (from date of cardiac MRI)
| Intervention | Participants (Count of Participants) |
|---|---|
| Nonspecific Allograft Dysfunction | 0 |
| Normal Graft Function | 0 |
4 reviews available for prednisone and Coronary Disease
| Article | Year |
|---|---|
PHYSIOLOGY AND PHARMACOLOGY OF FIBRINOLYSIS.
Topics: Adrenocorticotropic Hormone; Adsorption; Anabolic Agents; Biomedical Research; Coronary Disease; Cor | 1964 |
Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort.
Topics: Anti-Inflammatory Agents; Cohort Studies; Coronary Disease; Female; Humans; Hydroxychloroquine; Hypo | 2000 |
Prevention of restenosis after coronary angioplasty: a pharmacological approach.
Topics: Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Aspirin; Calcium Channel Blockers; Clinical | 1989 |
Current status of clinical cardiac transplantation.
Topics: Adult; Arteriosclerosis; Azathioprine; B-Lymphocytes; Brain Death; Cardiac Catheterization; Cardiomy | 1974 |
5 trials available for prednisone and Coronary Disease
| Article | Year |
|---|---|
Advancing immunosuppression therapy to counter the progression of cardiac allograft vasculopathy.
Topics: Azathioprine; Coronary Angiography; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Femal | 2005 |
Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Communicable Diseases; Coronary Disease; Cyclosporine; Dr | 1996 |
Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation.
Topics: Adolescent; Adult; Antibodies; Azathioprine; Chronic Disease; Coronary Disease; Coronary Vessels; Cy | 2000 |
Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation.
Topics: Adolescent; Adult; Antibodies; Azathioprine; Chronic Disease; Coronary Disease; Coronary Vessels; Cy | 2000 |
Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation.
Topics: Adolescent; Adult; Antibodies; Azathioprine; Chronic Disease; Coronary Disease; Coronary Vessels; Cy | 2000 |
Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation.
Topics: Adolescent; Adult; Antibodies; Azathioprine; Chronic Disease; Coronary Disease; Coronary Vessels; Cy | 2000 |
A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty.
Topics: Angiography; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Female; Follow- | 1989 |
Prevention of restenosis after coronary angioplasty: a pharmacological approach.
Topics: Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Aspirin; Calcium Channel Blockers; Clinical | 1989 |
62 other studies available for prednisone and Coronary Disease
| Article | Year |
|---|---|
ARTIFICIAL ELECTRICAL PACING FOR HEART BLOCK: A REVIEW BASED ON TWENTY-FOUR CASES TREATED WITH IMPLANTED PACEMAKERS.
Topics: Adams-Stokes Syndrome; Cardiac Surgical Procedures; Coronary Disease; Ephedrine; Epinephrine; Heart | 1964 |
[PHARMACOLOGICAL THERAPY OF DISORDERS OF ATRIO-VENTRICULAR CONDUCTION IN THE AGED].
Topics: Atrial Flutter; Chlorothiazide; Coronary Disease; Geriatrics; Heart Block; Heart Conduction System; | 1964 |
PHARMACOLOGICAL ENCHANCEMENT OF FIBRINOLYTIC ACTIVITY OF BLOOD.
Topics: Adrenal Cortex Hormones; Anabolic Agents; Arteriosclerosis; Chlorpropamide; Coronary Disease; Fibrin | 1964 |
NEUROTRICHINOSIS.
Topics: Adrenocorticotropic Hormone; Coronary Disease; Electrocardiography; Humans; Meningitis; Neurologic M | 1964 |
Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents; Chi-Square Distribution; Cholesterol, HDL; Coronary Disease; Diabet | 2003 |
Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression.
Topics: Adult; Age of Onset; Anti-Inflammatory Agents; Body Weight; Coronary Angiography; Coronary Disease; | 2004 |
Images in cardiovascular medicine. Detection of active coronary arterial vasculitis using magnetic resonance imaging in Kawasaki disease.
Topics: Aspirin; Coronary Disease; Humans; Immunoglobulins, Intravenous; Infant; Magnetic Resonance Imaging; | 2005 |
Acquired immune cytopenias post-cardiac transplantation respond to rituximab.
Topics: Anemia, Aplastic; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Mur | 2007 |
Acute pleuropericarditis after coronary stenting: a case report.
Topics: Acute Disease; Aged; Coronary Disease; Coronary Vessels; Echocardiography; Electrocardiography; Huma | 2006 |
Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus.
Topics: Adolescent; Adult; Azathioprine; Cicatrix; Coronary Disease; Exercise Test; Female; Heart; Humans; L | 1984 |
[Interstitial pneumonitis and amiodarone].
Topics: Aged; Amiodarone; Benzofurans; Coronary Disease; Humans; Male; Middle Aged; Prednisone; Pulmonary Fi | 1984 |
[Myocardial infarct, acute coronary insufficiency and sudden death in lymphogranulomatosis patients after irradiation of the mediastinum].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Coronary Disease; Cyclophospha | 1983 |
Life-threatening idiopathic anaphylaxis associated with hyperimmunoglobulinemia E.
Topics: Anaphylaxis; Cimetidine; Coronary Disease; Diphenhydramine; Humans; Hydroxyzine; Hypergammaglobuline | 1984 |
Inflammatory disorders of muscle. Cardiac abnormalities.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiomyopathies; Coronary Disease; Creatine Kinase; Dermatomyosi | 1984 |
Ischemic heart disease in systemic lupus erythematosus in the young patient: report of six cases.
Topics: Adolescent; Adult; Age Factors; Angina Pectoris; Arteritis; Coronary Angiography; Coronary Artery By | 1982 |
Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis.
Topics: Adult; Blood Pressure; Body Weight; Cholesterol; Coronary Disease; Female; Humans; Hydroxychloroquin | 1994 |
Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression.
Topics: Azathioprine; Child; Coronary Angiography; Coronary Disease; Cyclosporine; Follow-Up Studies; Graft | 1993 |
Unstable angina in a man with joint pain.
Topics: Angina, Unstable; Arthritis, Rheumatoid; Coronary Disease; Diagnosis, Differential; Edema; Humans; M | 1993 |
Heart transplantation in patients with diabetic end-organ damage before transplantation.
Topics: Actuarial Analysis; Case-Control Studies; Contraindications; Coronary Disease; Diabetic Angiopathies | 1996 |
Idiopathic myocardial vasculitis presenting as restrictive cardiomyopathy.
Topics: Alkylating Agents; Anti-Inflammatory Agents; Atrial Function; Biopsy; Blood Pressure; Cardiomyopathy | 1997 |
Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Coronary Disease; Cyclosporine; Drug Thera | 1998 |
Characteristics of long-term renal transplant survivors.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Child, Preschool; Coronary Disease; Female; Follow- | 1998 |
Global biventricular dysfunction in patients with asymptomatic coronary artery disease may be caused by myocarditis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Autoimmune Diseases; Azathioprine; Biopsy; Cardiomy | 1999 |
Histologically proven myocarditis in patients with biventricular dysfunction and severe asymptomatic coronary artery disease.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Biopsy; Coronary Angiography; Coronary Disease; Echoc | 1999 |
Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Coronary Disease; Cyclosporine; Femal | 2000 |
Medical issues in treating renal transplant patients.
Topics: Anti-Inflammatory Agents; Coronary Disease; Diabetes Mellitus, Type 2; Humans; Hypertension; Immunos | 2001 |
High incidence of post-transplant diabetes mellitus in Kuwait.
Topics: Adult; Azathioprine; Cause of Death; Coronary Disease; Cyclosporine; Diabetes Mellitus; Female; Graf | 2002 |
Cardiac transplantation: review of seven years' experience.
Topics: Azathioprine; Coronary Disease; Graft Rejection; Heart Transplantation; Immunosuppression Therapy; P | 1976 |
Hyperlipidemia in pediatric hemodialysis and renal transplant patients. Associated with coronary artery disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Coronary Disease; Coronary Vessels; Dietary | 1976 |
Renal transplantation in the older age group.
Topics: Acute Kidney Injury; Age Factors; Aged; Azathioprine; Cadaver; Coronary Disease; Diabetes Complicati | 1975 |
Acute idiopathic pericarditis in the aged.
Topics: Acute Disease; Age Factors; Aged; Aspirin; Coronary Disease; Diagnosis, Differential; Female; Humans | 1975 |
Risk factors for coronary artery disease in patients with systemic lupus erythematosus.
Topics: Adult; Age Factors; Cholesterol; Coronary Disease; Female; Humans; Hypertension; Logistic Models; Lu | 1992 |
Left main coronary stenosis by a mediastinal lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Coronary Disease; Cyclophosphamide; Humans; Lymphoma | 1992 |
Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices.
Topics: Adolescent; Adult; Baltimore; Cohort Studies; Coronary Disease; Cross-Sectional Studies; Female; Hos | 1992 |
Relationship of immunosuppression and serum lipids to the development of coronary arterial disease in the transplanted heart.
Topics: Adult; Age Factors; Azathioprine; Cholesterol; Coronary Disease; Cyclosporins; Female; Heart Transpl | 1991 |
Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation.
Topics: Actuarial Analysis; Azathioprine; Coronary Disease; Cyclosporins; Drug Therapy, Combination; Female; | 1990 |
Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.
Topics: Azathioprine; Cohort Studies; Coronary Disease; Cyclosporins; Female; Graft Rejection; Heart Transpl | 1989 |
Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy.
Topics: Azathioprine; Coronary Disease; Cyclosporins; Female; Graft Rejection; Heart Transplantation; Histoc | 1989 |
Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients.
Topics: Adolescent; Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cyclosporins; | 1988 |
Present expectations in cardiac transplantation.
Topics: Adolescent; Adult; Azathioprine; Cardiomyopathies; Child; Child, Preschool; Coronary Disease; Cyclos | 1987 |
Lipid mediators in organ transplantation: does cyclosporine accelerate coronary atherosclerosis?
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Child; Coronary Disease; Cyclosporins; Female | 1987 |
Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.
Topics: Adult; Coronary Angiography; Coronary Disease; Coronary Vessels; Cyclosporins; Graft Rejection; Hear | 1987 |
Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.
Topics: Adult; Coronary Angiography; Coronary Disease; Coronary Vessels; Cyclosporins; Graft Rejection; Hear | 1987 |
Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.
Topics: Adult; Coronary Angiography; Coronary Disease; Coronary Vessels; Cyclosporins; Graft Rejection; Hear | 1987 |
Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.
Topics: Adult; Coronary Angiography; Coronary Disease; Coronary Vessels; Cyclosporins; Graft Rejection; Hear | 1987 |
Renal transplantation in the older recipient.
Topics: Age Factors; Antilymphocyte Serum; Azathioprine; Cadaver; Cardiomyopathies; Coronary Disease; Diabet | 1985 |
Cyclosporine in heart and heart-lung transplantation.
Topics: Adult; Bacterial Infections; Biopsy; Coronary Disease; Cyclosporins; Female; Graft Rejection; Heart | 1985 |
Amiodarone. The dilemma of hyperthyroxinaemia and the treatment of thyrotoxicosis.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Carbimazole; Coronary Disease; Humans; Hyperthy | 1985 |
[Heart diseases in collagenoses].
Topics: Adult; Amyloidosis; Cardiac Complexes, Premature; Cardiomegaly; Collagen Diseases; Coronary Disease; | 1970 |
[Therapy of extrasystoles].
Topics: Cardiac Complexes, Premature; Coronary Disease; Digitalis Glycosides; Electrocardiography; Humans; P | 1968 |
[On a case of periarteritis nodosa with 10-year evolution].
Topics: Arteries; Coronary Disease; Glomerulonephritis; Humans; Kidney; Male; Middle Aged; Muscles; Polyarte | 1971 |
Acute rejection in the long-term cardiac transplant survivor. Clinical diagnosis, treatment and significance.
Topics: Arteriosclerosis; Azathioprine; Biopsy; Coronary Disease; Cyclophosphamide; Electrocardiography; End | 1974 |
Cardiac allograft pathology in Rhesus monkeys.
Topics: Animals; Antilymphocyte Serum; Arteriosclerosis; Azathioprine; Coronary Disease; Coronary Vessels; G | 1973 |
Experience with endocarditis in a large kidney disease program.
Topics: Adult; Aged; Aortic Valve; Coronary Disease; Corynebacterium Infections; Endocarditis, Bacterial; Fe | 1973 |
[Hyperhaptoglobinemia in chronic alcoholics].
Topics: Alcoholism; Anti-Inflammatory Agents; Blood Protein Disorders; Chronic Disease; Coronary Disease; Do | 1973 |
Roentgenologic aspects of cardiac transplantation. Postoperative pulmonary infections.
Topics: Adult; Azathioprine; Biopsy; Cardiomyopathies; Coronary Disease; Female; Heart Transplantation; Huma | 1971 |
Immunofluorescence studies in recent myocardial infarction.
Topics: Adult; Aged; Autoantibodies; Cardiac Surgical Procedures; Coronary Disease; Cortisone; Fluorescent A | 1971 |
Myocardial changes and kidney transplantation. Lesions in patients receiving immunosuppressive therapy.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Arteriosclerosis; Autopsy; Azathioprine; Candida; Car | 1969 |
[3 cases of allogenic heart graft in man].
Topics: Adult; Angiocardiography; Azathioprine; Coronary Disease; Electrocardiography; Globulins; Heart Fail | 1969 |
Treatment of gangrene of the lower extremities.
Topics: Age Factors; Aged; Amputation, Surgical; Coronary Disease; Diabetes Complications; Female; Gangrene; | 1971 |
The overnight urinary reducing substances test in degenerative vascular diseases.
Topics: Adult; Aged; Carbohydrate Metabolism; Coronary Disease; Female; Glucose Tolerance Test; Humans; Male | 1966 |
Coronary occlusion in rheumatoid arthritis.
Topics: Arthritis, Juvenile; Calcinosis; Child; Coronary Disease; Endomyocardial Fibrosis; Humans; Male; Pre | 1970 |
[Improvement induced with anti-rheumatic therapy in the angina syndrome in a subject with prior rheumatic fever].
Topics: Adult; Angina Pectoris; Angiography; Arteriosclerosis; Arteritis; Coronary Disease; Coronary Vessels | 1970 |
[Corticosteroid treatment of heart block with coronary occlusion].
Topics: Adrenal Cortex Hormones; Coronary Disease; Female; Heart Block; Humans; Middle Aged; Prednisone | 1967 |
Recurrent blanching of the tongue due to giant cell arteritis.
Topics: Aged; Coronary Disease; Female; Gangrene; Giant Cell Arteritis; Humans; Prednisone; Tongue; Tongue D | 1968 |